Moreover, β-catenin activation can cooperate with Pten heterozygous or homozygous deletion to promote prostate cancer progression, CRPC transition and metastatic potential [269,331,332,333], indicating a synergistic relationship exists between the PI3K-AKT-mTOR and WNT cascades. The gene discussed is MTOR; the disease is prostate carcinoma.